Search
for
Sort by
Research 571–600 of 1000+
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Can Artificial Intelligence “Hold” a Dermoscope?—The Evaluation of an Artificial Intelligence Chatbot to Translate the Dermoscopic Language
- Skin manifestations associated with systemic diseases – Part I
- Delivery of nanocarriers with dissolvable microneedles for skin treatments: Approaches and challenges
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- [Cutaneous manifestations of malabsorption diseases (author's transl)].
- Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science
- A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Stem Cells as a Target for the Delivery of Active Molecules to Skin by Topical Administration
- Structure and function of skin, hair and nails
- Type I Keratin 17 Protein Is Phosphorylated on Serine 44 by p90 Ribosomal Protein S6 Kinase 1 (RSK1) in a Growth- and Stress-dependent Fashion
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- Oral Presentations
- Dermoscopy in General Dermatology: A Practical Overview
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Structure and function of skin, hair and nails
- Pregnancy and Skin
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Proopiomelanocortin (POMC) and Psychodermatology
- Skin disease related to metabolic syndrome in women
- Off-label dermatologic uses of IL-23 inhibitors
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Transcriptional and epigenetic mechanisms governing epidermal stem cell regulation
- Family-related quality of life and burden in caregivers of patients with chronic skin diseases
- Advancing Hair Disease Diagnostics: A Deep Learning Approach Using Inception-ResNet v2 for Multi-Class Classification